美国 · SEC FORM 4
BlackRock Health Sciences Term Trust
BMEZ · NYSE · CIK 0001785971 · Closed-End Funds · Asset Management
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
0 同一窗口内观察到的 Form 4 交易行
0 sales · 0 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
当前 180 天窗口内没有 Form 4 交易事件。
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2024-10-16 · Saba Capital Management, L.P.; Weinstein Boaz.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 32,798
- 上期报告
- 83,940
- 日均成交量
- 128,882
- 回补天数
- ≤ 1.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2024-10-16 | Saba Capital Management, L.P.; Weinstein Boaz | 买入 (P) | Common Stock | 29,795 | USD 15.81 | USD 471,059 | SEC 申报 ↗ |
| 2024-10-15 | Saba Capital Management, L.P.; Weinstein Boaz | 买入 (P) | Common Stock | 34,921 | USD 15.81 | USD 552,101 | SEC 申报 ↗ |
| 2024-10-14 | Saba Capital Management, L.P.; Weinstein Boaz | 买入 (P) | Common Stock | 15,281 | USD 15.87 | USD 242,509 | SEC 申报 ↗ |
| 2024-10-01 | Saba Capital Management, L.P.; Weinstein Boaz | 买入 (P) | Common Stock | 9,526 | USD 15.79 | USD 150,416 | SEC 申报 ↗ |
| 2024-09-30 | Saba Capital Management, L.P.; Weinstein Boaz | 买入 (P) | Common Stock | 8,012 | USD 15.84 | USD 126,910 | SEC 申报 ↗ |
| 2024-09-27 | Saba Capital Management, L.P.; Weinstein Boaz | 买入 (P) | Common Stock | 1,633 | USD 15.89 | USD 25,948 | SEC 申报 ↗ |
| 2024-09-26 | Saba Capital Management, L.P.; Weinstein Boaz | 买入 (P) | Common Stock | 47,871 | USD 15.81 | USD 756,841 | SEC 申报 ↗ |
| 2024-09-25 | Saba Capital Management, L.P.; Weinstein Boaz | 买入 (P) | Common Stock | 300 | USD 15.73 | USD 4,719 | SEC 申报 ↗ |
| 2024-09-23 | Saba Capital Management, L.P.; Weinstein Boaz | 买入 (P) | Common Stock | 2,006 | USD 15.98 | USD 32,056 | SEC 申报 ↗ |
| 2024-09-19 | Saba Capital Management, L.P.; Weinstein Boaz | 买入 (P) | Common Stock | 15,455 | USD 16.14 | USD 249,444 | SEC 申报 ↗ |
| 2024-09-18 | Saba Capital Management, L.P.; Weinstein Boaz | 买入 (P) | Common Stock | 20,534 | USD 15.88 | USD 326,080 | SEC 申报 ↗ |
| 2024-09-17 | Saba Capital Management, L.P.; Weinstein Boaz | 买入 (P) | Common Stock | 27,148 | USD 15.93 | USD 432,468 | SEC 申报 ↗ |
| 2024-04-01 | Saba Capital Management, L.P.; Weinstein Boaz | 买入 (P) | Common Stock | 46,421 | USD 16.33 | USD 758,055 | SEC 申报 ↗ |
| 2024-03-28 | Saba Capital Management, L.P.; Weinstein Boaz | 买入 (P) | Common Stock | 16,297 | USD 16.33 | USD 266,130 | SEC 申报 ↗ |
| 2024-03-26 | Saba Capital Management, L.P.; Weinstein Boaz | 买入 (P) | Common Stock | 129,372 | USD 16.32 | USD 2,111,351 | SEC 申报 ↗ |
Form 4 申报证据
6 transaction lines in the latest 365-day window; 119 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-01-30 | Xie H Erin | 期权行权／转换 (M) | Common Stock | 25,676 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-30 | Xie H Erin | D (D) | Common Stock | 25,676 | USD 15.21 | USD 390,536 | SEC 申报 ↗ |
| 2026-01-30 | Liu Xiang | 期权行权／转换 (M) | Common Stock | 778 | USD — | USD — | SEC 申报 ↗ |
展开近期 Form 4 证据 (6 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-01-30 | Xie H Erin | 期权行权／转换 (M) | Common Stock | 25,676 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-30 | Xie H Erin | D (D) | Common Stock | 25,676 | USD 15.21 | USD 390,536 | SEC 申报 ↗ |
| 2026-01-30 | Liu Xiang | 期权行权／转换 (M) | Common Stock | 778 | USD — | USD — | SEC 申报 ↗ |
| 2026-01-30 | Liu Xiang | D (D) | Common Stock | 778 | USD 15.21 | USD 11,832 | SEC 申报 ↗ |
| 2025-12-19 | Fairbairn Robert W | 卖出 (S) | Common Stock | 0 | USD 14.96 | USD 6 | SEC 申报 ↗ |
| 2025-12-18 | Fairbairn Robert W | 卖出 (S) | Common Stock | 10,294 | USD 14.98 | USD 154,204 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | BMEZ |
| CIK | 0001785971 |
| 行业 | Closed-End Funds |
| 细分行业 | Asset Management Yahoo Finance |
| SEC SIC | Investment company (SEC forms N-2, N-2/A, N-CEN) |
| 交易所 | NYSE |
数据覆盖
| 本地 Form 4 历史 | 119 transaction lines from 2020-01-28 to 2026-01-30 102 P purchase lines · 2 S sale lines · 15 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.